Cargando…
Bisphosphonate associated osteomyelitis of the jaw in patients with bony exposure: prevention, a new way of thinking
OBJECTIVE: There is strong evidence of a link between the use of systemic bisphosphonates (BPs) and osteonecrosis of the jaw, especially in cancer patients. Among risk factors for BRONJ, tooth extraction and immune suppressive drugs seem to have significant role on bone healing. Therefore, the impor...
Autores principales: | TARDAST, Arezo, SJÖMAN, Reine, LØES, Sigbjørn, ABTAHI, Jahan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Faculdade de Odontologia de Bauru da Universidade de São Paulo
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4510666/ https://www.ncbi.nlm.nih.gov/pubmed/26221926 http://dx.doi.org/10.1590/1678-775720140506 |
Ejemplares similares
-
Bisphosphonate Associated Osteonecrosis of the Jaw: An Update on Pathophysiology, Risk Factors, and Treatment
por: Rasmusson, Lars, et al.
Publicado: (2014) -
Bisphosphonate-treatment of secondary chronic osteomyelitis of the jaw – a case report
por: Heimes, Diana, et al.
Publicado: (2023) -
Primary Chronic Osteomyelitis of the Jaws in Children: An Update on Pathophysiology, Radiological Findings, Treatment Strategies, and Prospective Analysis of Two Cases
por: Berglund, Caroline, et al.
Publicado: (2015) -
Bony Tumor of the Upper Jaw—Amputation
Publicado: (1853) -
Osteoclast profile of medication-related osteonecrosis of the jaw secondary to bisphosphonate therapy: a comparison with osteoradionecrosis and osteomyelitis
por: Gross, Christian, et al.
Publicado: (2017)